Helixgate https://validator.w3.org/feed/docs/rss2.html Software Can Solve CGT’s Sectors Traceability Challenges Lilly files six lawsuits in bid to shut down ‘black market’ for retatrutide Deaths reported after treatment with Neurocrine’s approved Prader-Willi drug Next 10 U.S. Biopharma Clusters 2026 IPO stock tracker: How newly public biotechs are performing Definium’s LSD asset beats analyst expectations in Phase 3 anxiety readout Lilly cracks down on black market for obesity asset retatrutide with six lawsuits STAT+: Pharmalittle: We’re reading about Lilly ‘black market’ lawsuits, pushback over Trump vaccine plan, and more STAT+: The secret AI-startup project I’ve been working on the last six months Sentynl bets up to $475M in licensing deal for Mereo’s rare lung disease asset BridgeBio continues ATTR ascent as Alnylam’s Amvuttra falls short of expectations STAT+: Biotech company co-founded by top autoimmune researcher lays out plans with antibody therapies Replimune finally wins approval, Q2 earnings wrap up, psychedelics stay in spotlight Opinion: Climate change is making people with chronic illness even sicker Why a missed promotion isn’t always about you With tech backing, AI biotechs force biopharma into ‘fail-fast’ drug development Steroid Curbs Chronic Lung Inflammation Without Weakening Immune Defenses Home Stopping statins in people over 75 at low risk for heart disease didn’t increase deaths  Parasite-Specific Protein Helps Toxoplasma Adapt to Crowded Conditions The State of Biotech 2026 Human iPSC-Derived Heart Assembloids Reproduce Valve Development and Disease STAT+: Trump is counting on the health care industry to remake vaccines. They’re pushing back instead Bispecific Antibody Purification’s Complexity Problem and How to Fix It Ex-Legend CEO takes helm at biotech startup scouring the globe for drugs How we know that splitting up the MMR vaccine could be dangerous FDA rejects ITM Isotope’s radiopharma therapy over manufacturing issues Indiana Emerges as a Leading U.S. Biopharma Hub Amgen lays groundwork for new R&D center in Hyderabad Chasing Dupixent, a biotech aims to make better antibody drugs for eczema Scholar Rock rejigs approval filing after FDA flags violations at Novo plant How South Carolina Became the Southeast’s Fastest Growing Biotech Hub After billions in deals, Insilico CEO promises: ‘You haven’t seen anything yet’ Epicrispr, Infinimmune snag combined $165M in VC cash Epicrispr lands $90M to advance epigenetic editing drug for rare muscle disease AbCellera’s menopause medicine ‘sets new efficacy bar’ for hot flashes Silence causes uproar in rare blood cancer space as data sets high bar for competitors Vaderis hauls in $152M to test an AKT-targeting drug Rare disease biotech investment grows but UK lags STAT+: Nurses seek a seat at the table as they fight expanding clinical AI Austria’s new growth fund could further bolster its dynamic biotech innovation economy BMS Chooses Houston for $2.3B Manufacturing Facility Host-aware Identification of Intrinsic Gene Expression Biopart Parameters using Combinatorial Libraries Biotech news from around the world Bacterial Trait-Finding and Gene Mapping Platform Speeds Microbial Engineering for Biotech Applications Trump returns to controversial vaccine policy with order questioning childhood schedule Candida auris Persists in Hair Follicles, Hijacks Immune Signaling BMS picks Texas for new $2.3B manufacturing campus Sionna cystic fibrosis drug fails key trial, removing threat to Vertex BaseMap ABE Launched for Off-Target Characterization in Base Editing Therapeutic Development